FIA
NNVC icon

Foundations Investment Advisors’s NanoViricides NNVC Stock Holding History

Foundations Investment Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9K Buy
10,105
+100
+1% +$137 ﹤0.01% 1197
2026
Q1 		$9.13K Buy
10,005
+5
+0.1% +$5 ﹤0.01% 1158
2025
Q4 		$11.3K Hold
10,000
– – ﹤0.01% 1103
2025
Q3 		$14.3K Hold
10,000
– – ﹤0.01% 1039
2025
Q2 		$14K Buy
+10,000
New +$13.7K ﹤0.01% 914

Other funds holding NNVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Foundations Investment Advisors's NNVC Position: Q2 2026 in Review

Foundations Investment Advisors increased its NanoViricides (NNVC) stake by 1% in Q2 2026, buying an estimated $137 and bringing the position to 10,105 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

Foundations Investment Advisors first reported a position in NNVC in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.3K in Q3 2025. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Foundations Investment Advisors held 10,105 shares of NanoViricides worth $13.9K as of Q2 2026.
  • Foundations Investment Advisors bought 100 NanoViricides shares in Q2 2026, an estimated $137.
  • NanoViricides made up ﹤0.01% of Foundations Investment Advisors's portfolio in Q2 2026, its #1197 holding.
  • Foundations Investment Advisors first reported a position in NanoViricides in Q2 2025 and has held it in 5 quarters since.
  • Foundations Investment Advisors's NanoViricides position peaked at $14.3K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.